Clinical Trials Directory

Trials / Completed

CompletedNCT06597708

Dietary Diversities: Exploring the Influence of Keto Diet and Intermittent Fasting on Oral Health and Salivary Inflammatory Biomarkers

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Al-Mustansiriyah University · Academic / Other
Sex
All
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the impact of short term, two distinct dietary interventions, namely the Keto diet and Intermittent Fasting on oral health by measuring the severity of: * Periodontal diseases (Gingivitis). * Oral health status (Plaque index). As well as measuring the impact of these different dietary pattern on the levels of C- Reactive Protein, IL-6, TNF-a in mean of inflammatory biomarkers as well as LL- 37 peptide as well as measuring salivary flow and ph. Objectives of the study 1. Evaluate the impact of Keto diet and Intermittent Fasting on oral health among the Iraqi population. 2. Assess changes in inflammatory biomarkers within the study groups before and after the intervention period. 3. Compare the effects of Keto diet and Intermittent Fasting on oral health and inflammatory biomarkers between the two intervention groups. 4. Examine the variations in oral health and inflammatory biomarkers within each group by comparing the baseline (Iraqi diet) and post-intervention stages. 5. Investigate the influence of Keto diet and Intermittent Fasting on the levels of LL37, an antimicrobial peptide.

Conditions

Interventions

TypeNameDescription
BEHAVIORALketo dietThey were advised to eat ad libitum but to limit their carbohydrate intake to a maximum of 20-40 g/day to derive at leasut 75%, 15-20%, and 5-10% of total energy from fats, protein, and carbohydrates, respectively.
BEHAVIORALintermittent fasting with calorie restrictionThe 16/8 TRF group was asked to consume their daily calorie intake during an 8-hour window during the daytime and then fast for the remaining 16 hours each day throughout the intervention period.

Timeline

Start date
2024-02-01
Primary completion
2024-06-01
Completion
2024-06-30
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT06597708. Inclusion in this directory is not an endorsement.